-
AI & Machine Learning in Biotechnology2 weeks ago
OrbiMed-backed Pinnacle adds $89M series B to power oral peptide pipeline
Oral peptide specialist Pinnacle Medicines has secured an $89 million series B with backing from investors in the U.S. and China, bringing the company’s total fundraising...
-
AI & Machine Learning in Biotechnology2 weeks ago
Wave crashes after obesity trial tracks 1% dip in body weight over 6 months
Wave Life Sciences linked its obesity drug candidate to a 1% dip in body weight after six months, leading investors to drive the stock down more...
-
AI & Machine Learning in Biotechnology2 weeks agoSTAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
The Food and Drug Administration on Wednesday approved a new medicine from Denali Therapeutics for a condition called Hunter syndrome, a notable decision by the agency...
-
AI & Machine Learning in Biotechnology2 weeks agoSTAT+: A 2023 health AI bet that seems to be paying off
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in...
-
AI & Machine Learning in Biotechnology2 weeks agoSTAT+: Sarepta Therapeutics shares rise on early promise for rare disease drugs
Sarepta Therapeutics’ next crop of medicines for muscular dystrophy appear to be safe and effective in early clinical trials, the company said, a positive though incremental...
-
AI & Machine Learning in Biotechnology2 weeks ago
Merck, girding for Keytruda cliff, flies toward promising CML asset with $6.7B Terns acquisition
Merck and Terns Pharmaceuticals have agreed to a $6.7 billion all-cash buyout that delivers a prized leukemia asset to the New Jersey Big Pharma.Read More
-
AI & Machine Learning in Biotechnology2 weeks agoOpinion: We’re launching a new CMS pilot program to help children with complex conditions
Our public health programs are failing the children who need them most. Together, Medicaid and the Children’s Health Insurance Program (CHIP) cover half of all children...
-
AI & Machine Learning in Biotechnology2 weeks agoSTAT+: FTC strikes proposed deal with CVS over charges its PBM manipulated insulin prices, impeded access
The Federal Trade Commission reached a proposed settlement with CVS Caremark, one of the largest pharmacy benefit managers in the U.S., over allegations the company artificially...
-
AI & Machine Learning in Biotechnology2 weeks agoSTAT+: Drug company penalties for paying kickbacks to doctors failed to dent bottom lines, analysis finds
Pharmaceutical companies that were penalized for kickbacks paid only 2.2% of their U.S. revenue generated by selling drugs that were the focus of the alleged violations...
-
AI & Machine Learning in Biotechnology2 weeks agoSTAT+: FDA slams Soon-Shiong and ImmunityBio for making ‘false and misleading’ claims about a drug
Patrick Soon-Shiong, a controversial figure in the biotech industry, was harshly criticized by the U.S. Food and Drug Administration for making several false and misleading claims...
STAT+: Merck’s experimental HIV prevention pill could be made for less than $5 a year, researchers say
A star scientist showed that better genetics lessons could reduce racism. It was the death knell for his career
